238 related articles for article (PubMed ID: 20104550)
1. Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands.
Immel TA; Groth U; Huhn T
Chemistry; 2010 Mar; 16(9):2775-89. PubMed ID: 20104550
[TBL] [Abstract][Full Text] [Related]
2. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity and hydrolysis of trans-Ti(IV) complexes of salen ligands: structure-activity relationship studies.
Tzubery A; Tshuva EY
Inorg Chem; 2012 Feb; 51(3):1796-804. PubMed ID: 22220885
[TBL] [Abstract][Full Text] [Related]
5. Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.
Meker S; Manna CM; Peri D; Tshuva EY
Dalton Trans; 2011 Oct; 40(38):9802-9. PubMed ID: 21874187
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic dinuclear titanium-salan complexes: structural and biological characterization.
Immel TA; Grützke M; Batroff E; Groth U; Huhn T
J Inorg Biochem; 2012 Jan; 106(1):68-75. PubMed ID: 22112842
[TBL] [Abstract][Full Text] [Related]
7. New insights on the active species and mechanism of cytotoxicity of salan-Ti(IV) complexes: a stereochemical study.
Manna CM; Armony G; Tshuva EY
Inorg Chem; 2011 Oct; 50(20):10284-91. PubMed ID: 21923127
[TBL] [Abstract][Full Text] [Related]
8. Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.
Manna CM; Tshuva EY
Dalton Trans; 2010 Feb; 39(5):1182-4. PubMed ID: 20104339
[TBL] [Abstract][Full Text] [Related]
9. Unexpected influence of stereochemistry on the cytotoxicity of highly efficient Ti(IV) salan complexes: new mechanistic insights.
Manna CM; Armony G; Tshuva EY
Chemistry; 2011 Dec; 17(50):14094-103. PubMed ID: 22076809
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and X-ray structure analysis of a heptacoordinate titanium(IV)-bis-chelate with enhanced in vivo antitumor efficacy.
Immel TA; Grützke M; Späte AK; Groth U; Öhlschläger P; Huhn T
Chem Commun (Camb); 2012 Jun; 48(46):5790-2. PubMed ID: 22549385
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
12. Highly cytotoxic vanadium(V) complexes of salan ligands; insights on the role of hydrolysis.
Reytman L; Braitbard O; Tshuva EY
Dalton Trans; 2012 May; 41(17):5241-7. PubMed ID: 22415291
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates.
Zhao T; Grützke M; Götz KH; Druzhenko T; Huhn T
Dalton Trans; 2015 Oct; 44(37):16475-85. PubMed ID: 26325575
[TBL] [Abstract][Full Text] [Related]
14. Heteroleptic titanium(IV) catecholato/piperazine systems and their anti-cancer properties.
Hancock SL; Gati R; Mahon MF; Tshuva EY; Jones MD
Dalton Trans; 2014 Jan; 43(3):1380-5. PubMed ID: 24201896
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and application of vanadium-salan complexes in oxygen transfer reactions.
Adão P; Costa Pessoa J; Henriques RT; Kuznetsov ML; Avecilla F; Maurya MR; Kumar U; Correia I
Inorg Chem; 2009 Apr; 48(8):3542-61. PubMed ID: 19290614
[TBL] [Abstract][Full Text] [Related]
16. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
17. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
van Rijt SH; Peacock AF; Johnstone RD; Parsons S; Sadler PJ
Inorg Chem; 2009 Feb; 48(4):1753-62. PubMed ID: 19146436
[TBL] [Abstract][Full Text] [Related]
18. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
[TBL] [Abstract][Full Text] [Related]
19. High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.
Meker S; Margulis-Goshen K; Weiss E; Magdassi S; Tshuva EY
Angew Chem Int Ed Engl; 2012 Oct; 51(42):10515-7. PubMed ID: 22961758
[TBL] [Abstract][Full Text] [Related]
20. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Peacock AF; Parsons S; Sadler PJ
J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
